跳至主要内容
临床试验/IRCT20170925036401N1
IRCT20170925036401N1招募中未知

Comparison of the efficacy of intracoronary and intravenous Eptifibatide and intracoronary Retaplase on coronary blood flow in patients undergoing PPCI at Dr.Heshmat hospital during 2017-2018 (Randomized clinical trial study)

Rasht University of Medical Sciences0 个研究点目标入组 160 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • ischemic tipic chest pain extending more than 30 min, STelevation more than 1 mm in at least 2 leads with the same name, all patients with STEMI candidate for primary PCI, myocardial infarction not extending more than 12 hours, having life expectancy not less than 6 months, consent for participation in the study, age 18 to 80 years, no evidence for prior myocardial infarction, not having contraindications for reteplase or eptifibatide, not having left bundle branch block, not using GPIIb/IIIa in recent two weeks.

排除标准

  • rescue PCI after thrombolytic therapy, emergency CABG, cardiogenic shock, atrial fibrillation TIMI flow grade 3 in primary angiography(ie, having normal blood flow in coronary arteries) simultaneously presence in another intervention study

研究者

发起方
Rasht University of Medical Sciences

相似试验

effect of eptifibatide and reteplase on primary... | 临床试验